Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
74.80
+3.84 (5.41%)
Jun 9, 2025, 3:29 PM IST
NSE:LOTUSEYE Revenue
In the fiscal year ending March 31, 2025, Lotus Eye Hospital and Institute had annual revenue of 495.63M INR with 2.81% growth. Lotus Eye Hospital and Institute had revenue of 115.13M in the quarter ending March 31, 2025, with 5.78% growth.
Revenue
495.63M
Revenue Growth
+2.81%
P/S Ratio
2.98
Revenue / Employee
1.48M
Employees
336
Market Cap
1.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 495.63M | 13.53M | 2.81% |
Mar 31, 2024 | 482.10M | 11.66M | 2.48% |
Mar 31, 2023 | 470.44M | 81.34M | 20.90% |
Mar 31, 2022 | 389.10M | 65.51M | 20.24% |
Mar 31, 2021 | 323.59M | -81.94M | -20.21% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |